Table 1.
Sp. | Name | Family | Function | eSTK | Phospho-residue(s) | Domain | Effect on DNA binding | In vitro or In vivo | bRef. |
---|---|---|---|---|---|---|---|---|---|
S. aureus | SarA | SarA/ MgrA | Virulence | Stk1 (PknB), SA0077 (Stk2) | Thr(s)/ Ser(s)/C9 | DD | Increase/ Decrease | In vitro, in vivo | 84,88 |
SarZ | SarA/ MgrA | Redox | Stk1 (PknB) | C13 | DD | Decrease | In vitro, in vivo | 88 | |
MgrA | SarA/ MgrA | Antibiotic resistance | Stk1 (PknB) | S110, S113, C11 | DD | Decrease | In vitro, in vivo | 82,88 | |
CymR | SarA/ MgrA | Cysteine metabolism | Stk1 (PknB) | C25 | DD | Unknown | In vitro, in vivo | 88 | |
GraR | TCS | Antibiotic resistance | Stk1 (PknB) | T128, T130, T149 | DBD | Increase | In vitro | 102 | |
CcpA | LysR | Central metabolism/virulence | Stk1 (PknB) | T18, T33 | DBD | Decrease | In vitro, in vivo* | 97 | |
VraR | NarL | Antibiotic resistance | Stk1 (PknB) | T106, T119, T175 T178 | REC, DBD | Decrease | In vitro, in vivo* | 103 | |
M. tuberculosis | VirS | AraC | Stress response | PknK | Unknown | Unknown | Unknown | In vitro, in vivo* | 129 |
DosR | TCS-like | Redox, Dormancy | PknH | T198, T205 | REC | Increase | In vitro | 108 | |
EmbR | SARP | Cell wall modification | PknA, PknB, PknH | Thr(s), T209 | FHA, BTA | Increase | In vitro, in vivo | 112,118,119 | |
Rv0681 | TetR | Unknown | PknH | T35 | DBD | Unknown | In vitro | 119 | |
EthR | TetR | Antibiotic resistance | PknF | T2, T3, S4, S7 | Un-structured | Increase | In vitro | 122 | |
Rv2175c | TCS | Cell envelope | PknL | T9 | Un-structured | Unaffected | In vitro | 125 | |
RshA | anti-σ factor | Stress response | PknB | T94 | Unknown | Unknown | In vitro, in vivo | 131 | |
SigH | σ factor | Stress response | PknB | T26, T106 | Unknown | Unknown | In vitro, in vivo | 131 | |
Rv0516c | anti-anti-σ factor | Unknown | PknD | T2 | Unknown | Unknown | In vitro, in vivo | 132 | |
GBS | CovR | OmpR/ PhoB | Virulence | Stk1 | T65 | REC | Decrease | In vitro, in vivo | 138,139 |
GAS | WalR | OmpR/ PhoB | Cell wall, division | SP-STK | Thr(s) | Unknown | Unknown | In vitro, in vivo | 10 |
CovR | OmpR/ PhoB | Virulence | SP-STK | T65 | Unknown | Increase | In vitro, in vivo | 139 | |
S. pneumoniae | RitR | OmpR/ PhoB | Iron uptake, ROS stress | StkP | Unknown | DBD | Unknown | In vitro | 24 |
RR06 | OmpR/ PhoB | Adhesion | StkP | Thr(s) | Unknown | Increase | In vitro, in vivo | 149 |
DBD, DNA-Binding Domain; REC, Receiver Domain; DD, Dimerization Domain; σ, Sigma Factor; TCS, Two-Component System; FHA, Fork Head-Associated domain; BTA, Bacterial Transcriptional Activation domain; T or Thr, Threonine residue; S or Ser, Serine residue; C, Cysteine residue. Asterisk (*) denotes the use of a heterologous E. coli over-expression system to determine in vivo phosphorylation. GBS, Group B Streptococci (S. agalactiae); GAS, Group A Streptococci (S. pyogenes).
References where the phospho-modifications were identified.